Microangiopathic hemolytic anemia (MAHA) occurs when turbulence in the blood destroys red blood cells. This leads to symptoms such as tiredness and shortness of breath. Certain treatments are ...

Diagnosis Thrombotic microangiopathic hemolytic anemia with a possible underlying diagnosis of malignant hypertension, antiphospholipid antibody syndrome, catastrophic antiphospholipid antibody ...

Understanding of the pathophysiology of thrombotic microangiopathies — a group of rare yet life-threatening hematologic conditions — has evolved in recent years along with better access to diagnostic ...

Common Disorders Associated with Microangiopathic Hemolytic Anemia and Thrombocytopenia. Knowledge of the pathogenesis, management, and outcomes of the primary TMA syndromes has accelerated in ...

How should this case be managed? In this article, the term “thrombotic thrombocytopenic purpura” is used to describe microangiopathic hemolytic anemia and thrombocytopenia occurring in adults ...

Genentech has received reports of several cases of microangiopathic hemolytic anemia (MAHA) in patients with solid tumors receiving Avastin (bevacizumab) in combination with Sutent (sunitinib ...

A: Diagnosis is the most difficult part. When a clinician sees a person who has evidence of a microangiopathic hemolytic anemia — including low haptoglobin, elevated LDH, elevated indirect ...

The hallmark feature of this obstructed microcirculation is microangiopathic hemolytic anemia, which is characterized by fragmentation of erythrocytes and the characteristic presence of ...

These results, taken in totality, were consistent with hemolytic anemia. There were no previous laboratory results for comparison. The answer is both (a) and (e). Both microangiopathic anemia and ...

To be enrolled in the trial, patients with aHUS must either (1) have demonstrated thrombocytopenia, evidence of microangiopathic hemolytic anemia, and elevated creatinine despite at least four ...